Cremonese central defender Matteo Bianchetti has suffered a new injury which will continue his absence from the team. After missing the last three matches - on the bench against Pisa, not called up against Juve Stabia and Mantova - the club has published a new medical bulletin which confirms the seriousness of the problem.

According to the information provided by the Cremonese medical technician, Bianchetti underwent further instrumental tests. In addition to the already known blunt trauma to the right temporomandibular joint, which occurred during the clash with Arezzo, a subluxation was detected which caused complications at the cervico-dorsal level. The subluxation, in fact, generated movement problems and pain in the neck and back area, making a more in-depth specialist evaluation necessary.

The club announced that the player will undergo a re-evaluation with a specialist in maxillofacial surgery. The objective is to precisely define the therapies to be adopted, both from a medical and physiotherapeutic point of view, to allow Bianchetti to return to the pitch in the safest way possible. Cremonese reiterated the importance of a complete recovery, avoiding throwing the defender into a risky situation.

The new bulletin does not provide a precise return date, but underlines that specialist evaluation is essential to establish a personalized rehabilitation plan. In the meantime, the team will continue to look for solutions to cover the central position, relying on reserve players and possible transfer acquisitions.

For Cremonese fans, Bianchetti's absence represents a significant loss, especially in view of the upcoming Serie B matches. The club, however, has expressed confidence in the midfielder's ability to return to form, and the technical staff will continue to closely monitor his evolution. In the meantime, the club is focusing on maintaining defensive solidity, trying to minimize the impact of this new injury on the calendar of upcoming matches.

TuttomercatowebThis article was rewritten and localized by ScoreLens based on the original report.
Read original ↗ ← Back to news